BIOMAT Database Logo BIOMAT Database Logo

In vivo transfer of antisense oligonucleotide against urinary kininase blunts deoxycorticosterone acetate-salt hypertension in rats. 2000

I Hayashi, and M Majima, and T Fujita, and T Okumura, and Y Kumagai, and N Tomita, and R Morishita, and J Higaki, and T Ogiwara
Department of Pharmacology, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara, Kanagawa 228-8555, Japan. hayashii@med.kitasato-u.ac.jp

We have previously reported that the renal kallikrein-kinin system suppressed the development of deoxycorticosterone acetate (DOCA)-salt hypertension. Kinins were degraded in the kidney mainly by carboxypeptidase Y (CPY)-like kininase. Blockade of renal kinin degradation may reduce hypertension in the developmental stage. We constructed an antisense oligonucleotide against rat CPY homologue (5'-CAT-CTC-TGC-TTC-CTT-GTG-TC-3', AS) and its randomized control oligonucleotide (5'-TCC-TTC-CTG-CTT-GAG-TTC-CT-3', RC), and prepared an HVJ-liposome complex that prolongs and increases the effectiveness of the antisense oligonucleotide. Antisense oligonucleotide was transfected (25 nmole rat(-1), in terms of nucleotide) into the kidney from the renal artery. Blood pressure was measured through a catheter inserted into the abdominal aorta. Mean blood pressure (MBP) in DOCA-salt treated (for 2 weeks) Sprague Dawley strain rats was 130+/-3 mmHg (n=11), and was reduced significantly (P<0.05) more by AS transfection (122+/-4 mmHg, n=6) than by RC treatment (137+/-6 mmHg, n=5) 4 days after the transfection. This reduction in MBP was accompanied by increased urinary sodium excretion (AS, 8.4+/-1.5 mmole day(-1); RC, 4.6+/-0.5 mmole day(-1), P<0.05) and a reduction in urinary CPY-like kininase activity. Ebelactone B (5 mg kg(-1), twice a day, p.o.), an inhibitor for urinary CPY-like kininase, also reduced MBP and induced natriuresis to the same degree as AS. Lisinopril, an inhibitor for angiotensin converting enzyme (ACE) failed to reduce the elevated MBP. These results suggest that CPY-like kininase may have more contribution than ACE to degrade kinin in the kidney, and that knockdown of CPY-like kininase in the kidney may partly prevent rat DOCA-salt hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D007705 Kinins A generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. (From Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 8th ed, p588) Kinin
D008297 Male Males
D002268 Carboxypeptidases Enzymes that act at a free C-terminus of a polypeptide to liberate a single amino acid residue. Carboxypeptidase
D003900 Desoxycorticosterone A steroid metabolite that is the 11-deoxy derivative of CORTICOSTERONE and the 21-hydroxy derivative of PROGESTERONE 21-Hydroxyprogesterone,Cortexone,Deoxycorticosterone,Desoxycortone,11-Decorticosterone,21-Hydroxy-4-pregnene-3,20-dione,11 Decorticosterone,21 Hydroxy 4 pregnene 3,20 dione,21 Hydroxyprogesterone
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012965 Sodium Chloride A ubiquitous sodium salt that is commonly used to season food. Sodium Chloride, (22)Na,Sodium Chloride, (24)NaCl
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D016376 Oligonucleotides, Antisense Short fragments of DNA or RNA that are used to alter the function of target RNAs or DNAs to which they hybridize. Anti-Sense Oligonucleotide,Antisense Oligonucleotide,Antisense Oligonucleotides,Anti-Sense Oligonucleotides,Anti Sense Oligonucleotide,Anti Sense Oligonucleotides,Oligonucleotide, Anti-Sense,Oligonucleotide, Antisense,Oligonucleotides, Anti-Sense

Related Publications

I Hayashi, and M Majima, and T Fujita, and T Okumura, and Y Kumagai, and N Tomita, and R Morishita, and J Higaki, and T Ogiwara
Ebelactone B, an inhibitor of urinary carboxypeptidase Y-like kininase, prevents the development of deoxycorticosterone acetate-salt hypertension in rats.
September 1995, European journal of pharmacology,
I Hayashi, and M Majima, and T Fujita, and T Okumura, and Y Kumagai, and N Tomita, and R Morishita, and J Higaki, and T Ogiwara
Antihypertensive effects of chicken extract against deoxycorticosterone acetate-salt-induced hypertension in rats.
October 2001, Biological & pharmaceutical bulletin,
I Hayashi, and M Majima, and T Fujita, and T Okumura, and Y Kumagai, and N Tomita, and R Morishita, and J Higaki, and T Ogiwara
Neurohumoral mechanisms in deoxycorticosterone acetate (DOCA)-salt hypertension in rats.
January 2010, Experimental physiology,
I Hayashi, and M Majima, and T Fujita, and T Okumura, and Y Kumagai, and N Tomita, and R Morishita, and J Higaki, and T Ogiwara
Estrogen metabolite 2-methoxyestradiol prevents hypertension in deoxycorticosterone acetate-salt rats.
February 2013, Cardiovascular drugs and therapy,
I Hayashi, and M Majima, and T Fujita, and T Okumura, and Y Kumagai, and N Tomita, and R Morishita, and J Higaki, and T Ogiwara
5-Carboxamidotryptamine attenuates the development of deoxycorticosterone acetate-salt hypertension in rats.
March 1995, European journal of pharmacology,
I Hayashi, and M Majima, and T Fujita, and T Okumura, and Y Kumagai, and N Tomita, and R Morishita, and J Higaki, and T Ogiwara
Chronic hyperinsulinemia augments deoxycorticosterone acetate-salt hypertension.
January 1994, Hypertension (Dallas, Tex. : 1979),
I Hayashi, and M Majima, and T Fujita, and T Okumura, and Y Kumagai, and N Tomita, and R Morishita, and J Higaki, and T Ogiwara
Altered coronary dilation in deoxycorticosterone acetate-salt hypertension.
December 2000, Journal of hypertension,
I Hayashi, and M Majima, and T Fujita, and T Okumura, and Y Kumagai, and N Tomita, and R Morishita, and J Higaki, and T Ogiwara
Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
July 2001, European journal of pharmacology,
I Hayashi, and M Majima, and T Fujita, and T Okumura, and Y Kumagai, and N Tomita, and R Morishita, and J Higaki, and T Ogiwara
Regulation of vasopressin receptors in deoxycorticosterone acetate-salt hypertension.
October 1992, Hypertension (Dallas, Tex. : 1979),
I Hayashi, and M Majima, and T Fujita, and T Okumura, and Y Kumagai, and N Tomita, and R Morishita, and J Higaki, and T Ogiwara
Deoxycorticosterone acetate-salt rats: hypertension and sympathoexcitation driven by increased NaCl levels.
April 2006, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!